Rewiring the heart: Stem cell therapy to restore normal cardiac excitability and conduction

Current Stem Cell Research and Therapy

Volumn 4, Issue 1, 2009, Pages 23-33

  Blank, A Christian ^a,b   van Veen, Toon A B ^a   Jonsson, Malin K B ^a   Zelen, Jirre S J ^a   Strengers, Jan L ^b   de Boer, Teun P ^a,c   van der Heyden, Marcel A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Arrhythmia; Atrioventricular node; Electrophysiology; Ik1; Pacemaker; Sinoatrial node; Stem cell

Indexed keywords

CONNEXIN 43; CONNEXIN 45; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL;

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; CELL DIFFERENTIATION; CELL REGENERATION; GENE EXPRESSION; HEART ATRIOVENTRICULAR NODE; HEART CONDUCTION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART EXCITATION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROARRHYTHMIA; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; ANIMAL; BIOLOGICAL RHYTHM; CELL MOTION; CONVALESCENCE; GENETIC ENGINEERING; GENETICS; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; BIOLOGICAL CLOCKS; CELL MOVEMENT; GENETIC ENGINEERING; HEART CONDUCTION SYSTEM; HUMANS; ION CHANNELS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION;

EID: 67849129192     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488809787169066     Document Type: Review

References (76)

1. 2+ content in cardiac muscle. Cell Calcium 2005; 38: 391-6.
2. Roden DM, Balser JR, George Jr AL, Anderson ME. Cardiac ion channels. Annu Rev Physiol 2002; 64: 431-75.
3. Söhl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 2003; 10: 173-80.
4. van Veen TA, van Rijen HV, Jongsma HJ. Physiology of cardiovascular gap junctions. Adv Cardiol 2006; 42: 18-40.
5. de Bakker JMT, van Rijen HVM. Electrocardiographic manifestation of anatomical substrates underlying post-myocardial infarction tachycardias. J Electrocardiol 2007; 40: S21-5.
6. Kléber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004; 84: 431-88.
7. Marbán E. Cardiac channelopathies. Nature 2002; 415: 213-8.
8. Michael G, Xiao L, Qi XY, Dobrev D, Nattel S. Remodelling of cardiac repolarization: How homeostatic responses can lead to arrhythmogenesis. Cardiovasc Res 2008; doi:10.1093/cvr/cvn266.
9. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005; 11: 367-8.
10. Menasché P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117: 1189-1200.
11. de Boer TP, van der Heyden MAG, Rook M, et al. Proarrhythmogenic potential of immature cardiomyocytes is triggered by low coupling and cluster size. Cardiovasc Res 2006; 71: 704-14.
12. Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res 2000; 47: 658-87.
13. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003; 93: 32-9.
14. Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi ME. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 2007; 25: 1136-44.
15. Satin J, Kehat I, Caspi O, et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol 2004; 559: 479-96.
16. Silvetti MS, Drago F, Grutter G, De Santis A, Di Ciommo V, Ravà L. Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace 2006; 8: 530-6.
17. Thambo JB, Bordachar P, Garrigue S, et al. Detrimental ventricular remodelling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation 2004; 110: 3766-72.
18. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22: 1282-9.
19. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005; 111: 11-20.
20. Cho HC, Kashiwakura Y, Marbán E. Creation of a biological pacemaker by cell fusion. Circ Res 2007; 100: 1112-5.
21. Miake J, Marbán E, Nuss HB. Biological pacemaker created by gene transfer. Nature 2002; 419: 132-3.
22. Qu J, Plotnikov AN, Danilo P, Jr., et al. Expression and function of a biological pacemaker in canine heart. Circulation 2003; 107: 1106-9.
23. Plotnikov AN, Sosunov EA, Qu J, et al. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation 2004; 109: 506-12.
24. Kashiwakura Y, Cho HC, Barth AS, Azene E, Marbán E. Gene transfer of a synthetic pacemaker channel into the heart: a novel strategy for biological pacing. Circulation 2006; 114: 1682-6.
25. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther 1995; 6: 1265-74.
26. Potapova I, Plotnikov A, Lu Z, et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 2004; 94: 952-9.
27. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 2007; 116: 706-13.
28. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282-6.
29. Goumans MJ, De Boer TP, Smits AM, et al. TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2007; 1: 138-49.
30. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003; 100: 12313-8.
31. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-76.
32. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004; 279: 11384-91.
33. Anversa P, Leri A, Kajstura J. Cardiac regeneration. J Am Coll Cardiol 2006; 47: 1769-76.
34. Tawara S. Das Reizleitungssystem des Säugetierherzens. Eine anatomische-histologische studie über das Atrioventricularbündel und die Purkinjeschen Fäden. 1906; Jena, Verlag v. Gustav Fischer.
35. Silverman ME, Grove D, Upshaw Jr CB. Why Does the Heart Beat? The Discovery of the Electrical System of the Heart. Circulation 2006; 113: 2775-81.
36. Efimov IR, Nikolski VP, Rothenberg F, et al. Structure-function relationship in the AV junction. Anat Rec A Discov Mol Cell Evol Biol 2004; 280: 952-65.
37. Anderson RH, Ho SY. The atrial connections of the specialized axis responsible for AV conduction. In: Mazgalev TN, Tchou PJ, Eds. Atrial-AV nodal electrophysiology: a view from the millennium. New York, Futura publishing company, Inc; 2000; 3-24.
38. Bharati S. Anatomic-morphologic relations between AV nodal structure and function in the normal and diseased heart. In: Mazgalev TN, Tchou PJ, Eds. Atrial-AV nodal electrophysiology: a view from the millennium. New York, Futura publishing company, Inc; 2000; 25-48.
39. Desplantez T, Dupont E, Severs NJ, Weingart R. Gap junction channels and cardiac impulse propagation. J Membr Biol 2007; 218: 13-28.
40. Petrecca K, Shrier A. Spatial distribution of ion channels, receptors, and innervation in the AV node. In: Mazgalev TN, Tchou PJ, Eds. Atrial-AV nodal electrophysiology: a view from the millennium. New York, Futura publishing company, Inc; 2000: 89-105.
41. Boyett MR, Inada S, Yoo S, et al. Connexins in the sinoatrial and atrioventricular nodes. Adv Cardiol 2006; 42: 175-97.
42. Li J, Greener ID, Inada S, et al. Computer three-dimensional reconstruction of the atrioventricular node. Circ Res 2008; 102: 975-85.
43. Choi YH, Stamm C, Hammer PE, et al. Cardiac conduction through engineered tissue. Am J Pathol 2006; 169: 72-85.
44. Bunch TJ, Mahapatra S, Bruce GK, et al. Impact of Transforming Growth Factor-β1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation 2006; 113: 2485-94.
45. Hagège A, Marolleau J, Vilquin J, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006; 114: 108-13.
46. Smits P, van Geuns R, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with sixmonth follow-up. J Am Coll Cardiol 2003; 42: 2063-9.
47. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003; 107: 2733-40.
48. Yang HT, Tweedie D, Wang S, et al. The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci USA. 2002; 99: 9225-30.
49. Abraham M, Henrikson C, Tung L, et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005; 97: 159-67.
50. Beeres S, Atsma D, van der Laarse A, et al. Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J Am Coll Cardiol 2005; 46: 1943-52.
51. Van Veen TA, de Bakker JMT, van der Heyden MAG. Mesenchymal stem cells repair conduction block. J Am Coll Cardiol 2006; 48: 219-20.
52. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104: 14068-73.
53. Urbanek K, Cesselli D, Rota M, et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 2006; 103: 9226-31.
54. Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell 2008; 132: 537-43.
55. T.P. de Boer, T.A.B. van Veen, M.K.B. Jonsson, et al. The functional electronome of cardiomyocytes differentiated from human cardiac progenitor cells. Heart Rhythm 2007; 4: S3.
56. Chen X, Wilson RM, Kubo H, et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res 2007; 100: 536-44.
57. Christman K, Lee R. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 2006; 48: 907-13.
58. Leor J, Aboulafia-Etzion S, Dar A, et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000; 102: 56-61.
59. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006; 12: 452-8.
60. Huang NF, Yu J, Sievers R, et al. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng 2005; 11: 1860-6.
61. Christman KL, Vardanian AJ, Fang Q, et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004; 44: 654-60.
62. Kofidis T, Lebl DR, Martinez EC, et al. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005; 112: 173-7.
63. Wilber DJ. Catheter ablation of ventricular tachycardia: two decades of progress. Heart Rhythm 2008; 5: S59-63.
64. Lubitz SA, Fischer A, Fuster V. Catheter ablation for atrial fibrillation. BMJ 2008; 336: 819-26.
65. K1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm 2005; 2: 316-24.
66. + current. Circ Res 2004; 94: 1332-9.
67. Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105: 511-9.
68. Miake J, Marbán E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominantnegative suppression. J Clin Invest 2003; 111: 1529-36.
69. K1 in the mouse heart leads to multiple abnormalities of cardiac excitability. Am J Physiol Heart Circ Physiol 2004; 287: H2790-802.
70. Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Comm 2005; 332: 1012-9.
71. K1 in the mouse heart is proarrhythmic. Basic Res Cardiol 2007; 102: 416-28.
72. K1) in the mouse heart accelerates and stabilizes rotors. J Physiol 2007; 578: 315-26.
73. Sasano T, McDonald AD, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med 2006; 12: 1256-8.
74. De boer TP, van Veen TAB, Houtman MJC, et al. Inhibition of cardiomyocytes automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells. Med Biol Eng Comput 2006; 44: 537-43.
75. Yankelson L, Feld Y, Bressler-Stramer T, et al. Cell therapy for modification of the myocardial electrophysiological substrate. Circulation 2008; 117: 720-31.
76. Mikawa T, Hurtado R. Development of the cardiac conduction system. Semin Cell Dev Biol 2007; 18: 90-100.